Klotho Neurosciences, Inc. Common Stock earnings per share and revenue
On --, KLTO reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
What were Klotho Neurosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q-- --?
For Q-- --, Klotho Neurosciences, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Klotho Neurosciences, Inc. Common Stock's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Klotho Neurosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 31, 2026.
What are the forecasts for Klotho Neurosciences, Inc. Common Stock's next earnings report?
Based on --
analysts, Klotho Neurosciences, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q4 2025.